121 related articles for article (PubMed ID: 8790562)
1. Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitis.
Aoki SK; Kuramoto IK; Anderson S; Schoening V; Rodriguez R; Fernando L; Sazama K; Holland PV
J Viral Hepat; 1994; 1(1):73-7. PubMed ID: 8790562
[TBL] [Abstract][Full Text] [Related]
2. Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C.
Aoki SK; Holland PV; Fernando LP; Kuramoto IK; Anderson S; Sazama K; Schoening V; Johnson P; Wilber JC; Fenner L
Blood; 1993 Aug; 82(3):1000-5. PubMed ID: 7687886
[TBL] [Abstract][Full Text] [Related]
3. Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: implications for infection control strategies in hemodialysis units.
Oliva JA; Ercilla G; Mallafre JM; Bruguera M; Carrió J; Pereira BJ
Int J Artif Organs; 1995 Feb; 18(2):73-7. PubMed ID: 7558399
[TBL] [Abstract][Full Text] [Related]
4. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
5. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
6. Transmission of hepatitis C by kidney transplantation--the risks.
Tesi RJ; Waller K; Morgan CJ; Delaney S; Elkhammas EA; Henry ML; Ferguson RM
Transplantation; 1994 Mar; 57(6):826-31. PubMed ID: 8154029
[TBL] [Abstract][Full Text] [Related]
7. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
8. Post-transfusion hepatitis revisited.
Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
[TBL] [Abstract][Full Text] [Related]
9. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
10. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?
Rowan BP; Smith A; Gleeson D; Hunt LP; Warnes TW
Gut; 1994 Apr; 35(4):542-6. PubMed ID: 8174994
[TBL] [Abstract][Full Text] [Related]
12. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors.
Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF
QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451
[TBL] [Abstract][Full Text] [Related]
13. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
[TBL] [Abstract][Full Text] [Related]
14. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
[TBL] [Abstract][Full Text] [Related]
15. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
16. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.
Operskalski EA; Mosley JW; Tobler LH; Fiebig EW; Nowicki MJ; Mimms LT; Gallarda J; Phelps BH; Busch MP; ;
Transfusion; 2003 Oct; 43(10):1433-41. PubMed ID: 14507276
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
18. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors.
Cable R; Badon S; Pray C; Popovsky MA
Transfusion; 1997 Feb; 37(2):206-10. PubMed ID: 9051097
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
20. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
Makris K; Kouvelis V; Drakopoulos I; Oikonomou E; Maniatis A
Transfus Med; 1995 Sep; 5(3):213-24. PubMed ID: 8593527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
